N Philippe Selected Research

N Philippe Research Topics

Disease

4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2005 - 01/2001
2	Infections 06/2008 - 04/2002
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2006 - 12/2005
2	Leukemia 12/2005 - 05/2005
2	Residual Neoplasm 03/2002 - 12/2000
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 04/2001 - 03/2000
2	Severe combined immunodeficiency with sensitivity to ionizing radiation 04/2001 - 03/2000
1	Aspergillosis 06/2008
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2008
1	Cardiotoxicity 12/2005
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 05/2005
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2005
1	Eosinophilia 05/2005
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 02/2005
1	2 Primary Biliary Cirrhosis 02/2005
1	Rheumatoid Arthritis 02/2005
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 02/2005
1	Alopecia (Baldness) 02/2005
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 02/2005
1	Cytopenia 02/2005
1	Myasthenia Gravis 02/2005
1	Acute Promyelocytic Leukemia 04/2004
1	Fatty Liver 01/2004
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2004
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2004
1	Muscle Hypotonia (Hypotonia) 01/2004
1	Lactic Acidosis 01/2004
1	Drug-Related Side Effects and Adverse Reactions 11/2001
1	Hypersensitivity (Allergy) 11/2001
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2001
1	Neoplasms (Cancer) 04/2001
1	Lupus Nephritis 04/2001
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2001
1	Nephritis 04/2001
1	Intestinal Perforation 01/2001
1	Pathologic Complete Response 01/2001
1	Insulin Resistance 04/2000
1	Hyperinsulinism (Hyperinsulinemia) 04/2000

Drug/Important Bio-Agent (IBA)

2	Imatinib Mesylate (Gleevec)FDA Link 04/2008 - 05/2005
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 05/2005 - 03/2002
2	Methotrexate (Mexate)FDA LinkGeneric 03/2002 - 04/2001
2	DNA (Deoxyribonucleic Acid)IBA 04/2001 - 03/2000
2	SteroidsIBA 04/2001 - 12/2000
1	Phosphotransferases (Kinase)IBA 04/2008
1	Dasatinib (BMS 354825)FDA Link 04/2008
1	Core Binding Factors (Core-Binding Factor)IBA 06/2006
1	AnthracyclinesIBA 12/2005
1	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2005
1	Tryptases (Tryptase)IBA 05/2005
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2005
1	Interleukin-5 (Interleukin 5)IBA 05/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2005
1	Inosine Triphosphate (ITP)IBA 02/2005
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2005
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2004
1	SaltsIBA 01/2004
1	Asparaginase (Elspar)FDA Link 03/2002
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2002
1	Proteins (Proteins, Gene)FDA Link 04/2001
1	AutoantibodiesIBA 04/2001
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2001
1	Insulin ReceptorIBA 04/2000
1	DNA Ligase ATPIBA 03/2000
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 03/2000

Therapy/Procedure

4	Therapeutics 05/2005 - 01/2001
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2005 - 01/2001
2	Drug Therapy (Chemotherapy) 12/2005 - 04/2004
1	Hematopoietic Stem Cell Transplantation 06/2008
1	Splenectomy 02/2005
1	Operative Surgical Procedures 04/2002
1	Medical Day Care (Partial Hospitalization) 04/2002
1	Radiotherapy 03/2002
1	Maintenance Chemotherapy 03/2002
1	Medication Errors (Medication Error) 11/2001
1	Cranial Irradiation 04/2001
1	Spinal Injections 04/2001